Big Bang Capital established its presence as a key participant in the Supply Chain industry in 2011, signifying a strategic entry into this sector. However, it was during the unprecedented circumstances of the pandemic that the company demonstrated remarkable agility by expanding its operations and capitalizing on emerging opportunities.
By strategically acquiring essential commodities, and critical medical supplies, directly from reputable factories in Southeast Asia, we successfully established a robust and efficient supply chain network. This approach allowed our company to circumvent intermediaries and cultivate direct relationships with manufacturers, ensuring an uninterrupted and expeditious flow of goods.
Notably, our company procured valuable assets known as product allocations, colloquially referred to as “future production.” These allocations represent a distinct advantage in the realm of supply chain management. By securing these allocations, we gained access to a substantial volume of goods that were